$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

암 치료 표적으로써 prostate apoptosis response-4 (Par-4)
Prostate Apoptosis Response-4 (Par-4) as a Cancer Therapeutic Target 원문보기

생명과학회지 = Journal of life science, v.25 no.8 = no.184, 2015년, pp.947 - 952  

우선민 (계명대학교 의과대학 면역학교실) ,  권택규 (계명대학교 의과대학 면역학교실)

초록
AI-Helper 아이콘AI-Helper

Par-4는 종양 억제 유전자로 암세포 선택적으로 세포사멸을 증진하는 기능을 가진다. Par-4 유전자는 nuclear localization sequences (NLS), leucine zipper (LZ), nuclear export sequence (NES), selective for apoptosis in cancer cells (SAC)의 네 가지 도메인을 가지고 있다. 이 중에서도 SAC 도메인이 Par-4에 의한 세포사멸에 중요한 역할을 하며, 이러한 Par-4의 활성화는 세포 내 경로와 세포 외 경로로 나누어진다. 세포질 내의 Par-4는 핵 내로 이동하여 NF-κB 매개의 세포 성장 경로를 억제하고 세포 밖으로 분비된 Par-4는 세포 표면에 존재하는 수용체인 GRP78과 결합하여 세포 사멸을 유도한다. 따라서 Par-4의 발현을 증가시키는 물질에 의한 세포 사멸뿐만 아니라 암세포에서 발현이 낮은 Par-4의 과발현을 통하여 세포사멸 민감화가 증진된다. 따라서 Par-4는 암 치료의 강력한 표적으로의 가능성을 가지고 있다.

Abstract AI-Helper 아이콘AI-Helper

Prostate apoptosis response-4 (Par-4) was originally identified in androgen-independent prostate cancer cells undergoing apoptosis. Par-4 is ubiquitously expressed in normal cells and tissues, but it is downregulated in several types of cancers. Par-4 is a 38 kDa tumor suppressor protein encoded by ...

주제어

AI 본문요약
AI-Helper 아이콘 AI-Helper

* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.

이론/모형

  • [3, 23, 28, 45]. 본 보고에서는 Par-4의 구조적 기능과 항암효과 및 작용 기전에 대하여 정리하였다.
본문요약 정보가 도움이 되었나요?

참고문헌 (51)

  1. Ahmed, M. M., Sheldon, D., Fruitwala, M. A., Venkatasubbarao, K., Lee, E. Y., Gupta, S., Wood, C., Mohiuddin, M. and Strodel, W. E. 2008. Downregulation of PAR-4, a pro-apoptotic gene, in pancreatic tumors harboring K-ras mutation. Int. J. Cancer 122, 63-70. 

  2. Almoguera, C., Shibata, D., Forrester, K., Martin, J., Arnheim, N. and Perucho, M. 1988. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53, 549-554. 

  3. Azmi, A. S., Ahmad, A., Banerjee, S., Rangnekar, V. M., Mohammad, R. M. and Sarkar, F. H. 2008. Chemoprevention of pancreatic cancer: characterization of Par-4 and its modulation by 3,3′ diindolylmethane (DIM). Pharm. Res. 25, 2117-2124. 

  4. Barkett, M. and Gilmore, T. D. 1999. Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene 18, 6910-6924. 

  5. Barradas, M., Monjas, A., Diaz-Meco, M. T., Serrano, M. and Moscat, J. 1999. The downregulation of the pro-apoptotic protein Par-4 is critical for Ras-induced survival and tumor progression. EMBO J. 18, 6362-6369. 

  6. Boehrer, S., Chow, K. U., Puccetti, E., Ruthardt, M., Godzisard, S., Krapohl, A., Schneider, B., Hoelzer, D., Mitrou, P. S., Rangnekar, V. M. and Weidmann, E. 2001. Deregulated expression of prostate apoptosis response gene-4 in less differentiated lymphocytes and inverse expressional patterns of par-4 and bcl-2 in acute lymphocytic leukemia. Hematol. J. 2, 103-107. 

  7. Bos, J. L. 1989. ras oncogenes in human cancer: a review. Cancer Res. 49, 4682-4689. 

  8. Burikhanov, R., Zhao, Y., Goswami, A., Qiu, S., Schwarze, S. R. and Rangnekar, V. M. 2009. The tumor suppressor Par-4 activates an extrinsic pathway for apoptosis. Cell 138, 377-388. 

  9. Chakraborty, M., Qiu, S. G., Vasudevan, K. M. and Rangnekar, V. M. 2001. Par-4 drives trafficking and activation of Fas and Fasl to induce prostate cancer cell apoptosis and tumor regression. Cancer Res. 61, 7255-7263. 

  10. Chaudhry, P., Singh, M., Parent, S. and Asselin, E. 2012. Prostate apoptosis response 4 (Par-4), a novel substrate of caspase-3 during apoptosis activation. Mol. Cell. Biol. 32, 826-839. 

  11. Cheema, S. K., Mishra, S. K., Rangnekar, V. M., Tari, A. M., Kumar, R. and Lopez-Berestein, G. 2003. Par-4 transcriptionally regulates Bcl-2 through a WT1-binding site on the bcl-2 promoter. J. Biol. Chem. 278, 19995-20005. 

  12. Cook, J., Krishnan, S., Ananth, S., Sells, S. F., Shi, Y., Walther, M. M., Linehan, W. M., Sukhatme, V. P., Weinstein, M. H. and Rangnekar, V. M. 1999. Decreased expression of the pro-apoptotic protein Par-4 in renal cell carcinoma. Oncogene 18, 1205-1208. 

  13. de Thonel, A., Hazoume, A., Kochin, V., Isoniemi, K., Jego, G., Fourmaux, E., Hammann, A., Mjahed, H., Filhol, O., Micheau, O., Rocchi, P., Mezger, V., Eriksson, J. E., Rangnekar, V. M. and Garrido, C. 2014. Regulation of the proapoptotic functions of prostate apoptosis response-4 (Par-4) by casein kinase 2 in prostate cancer cells. Cell Death Dis. 5, e1016. 

  14. Diaz-Meco, M. T., Lallena, M. J., Monjas, A., Frutos, S. and Moscat, J. 1999. Inactivation of the inhibitory kappaB protein kinase/nuclear factor kappaB pathway by Par-4 expression potentiates tumor necrosis factor alpha-induced apoptosis. J. Biol .Chem. 274, 19606-19612. 

  15. Diaz-Meco, M. T. and Moscat, J. 2008. Akt regulation and lung cancer: a novel role and mechanism of action for the tumor suppressor Par-4. Cell Cycle 7, 2817-2820. 

  16. Diaz-Meco, M. T., Municio, M. M., Frutos, S., Sanchez, P., Lozano, J., Sanz, L. and Moscat, J. 1996. The product of par-4, a gene induced during apoptosis, interacts selectively with the atypical isoforms of protein kinase C. Cell 86, 777-786. 

  17. Donninger, H., Hesson, L., Vos, M., Beebe, K., Gordon, L., Sidransky, D., Liu, J. W., Schlegel, T., Payne, S., Hartmann, A., Latif, F. and Clark, G. J. 2010. The Ras effector RASSF2 controls the PAR-4 tumor suppressor. Mol. Cell. Biol. 30, 2608-2620. 

  18. Downward, J. 2004. PI 3-kinase, Akt and cell survival. Semin. Cell Dev. Biol. 15, 177-182. 

  19. El-Guendy, N. and Rangnekar, V. M. 2003. Apoptosis by Par-4 in cancer and neurodegenerative diseases. Exp. Cell Res. 283, 51-66. 

  20. El-Guendy, N., Zhao, Y., Gurumurthy, S., Burikhanov, R. and Rangnekar, V. M. 2003. Identification of a unique core domain of par-4 sufficient for selective apoptosis induction in cancer cells. Mol. Cell. Biol. 23, 5516-5525. 

  21. Goswami, A., Burikhanov, R., de Thonel, A., Fujita, N., Goswami, M., Zhao, Y., Eriksson, J. E., Tsuruo, T. and Rangnekar, V. M. 2005. Binding and phosphorylation of par-4 by akt is essential for cancer cell survival. Mol. Cell 20, 33-44. 

  22. Gurumurthy, S., Goswami, A., Vasudevan, K. M. and Rangnekar, V. M. 2005. Phosphorylation of Par-4 by protein kinase A is critical for apoptosis. Mol. Cell. Biol. 25, 1146-1161. 

  23. Jagtap, J. C., Dawood, P., Shah, R. D., Chandrika, G., Natesh, K., Shiras, A., Hegde, A. S., Ranade, D. and Shastry, P. 2014. Expression and regulation of prostate apoptosis response-4 (Par-4) in human glioma stem cells in drug-inducedapoptosis. PLoS One. 9, e88505. 

  24. Jagtap, J. C., Parveen, D., Shah, R. D., Desai, A., Bhosale, D., Chugh, A., Ranade, D., Karnik, S., Khedkar, B., Mathur, A., Natesh, K., Chandrika, G. and Shastry, P. 2015. Secretory prostate apoptosis response (Par)-4 sensitizes multicellular spheroids (MCS) of glioblastoma multiforme cells to tamoxifen-inducedcell death. FEBS Open Bio. 5, 8-19. 

  25. Johnstone, R. W., See, R. H., Sells, S. F., Wang, J., Muthukkumar, S., Englert, C., Haber, D. A., Licht, J. D., Sugrue, S. P., Roberts, T., Rangnekar, V. M. and Shi, Y. 1996. A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms’ tumor suppressor WT1. Mol. Cell. Biol. 16, 6945-6956. 

  26. Johnstone, R. W., Tommerup, N., Hansen, C., Vissing, H. and Shi, Y. 1998. Mapping of the human PAWR (par-4) gene to chromosome 12q21. Genomics 53, 241-243. 

  27. Kimura, M., Furukawa, T., Abe, T., Yatsuoka, T., Youssef, E. M., Yokoyama, T., Ouyang, H., Ohnishi, Y., Sunamura, M., Kobari, M., Matsuno, S. and Horii, A. 1998. Identification of two common regions of allelic loss in chromosome arm 12q in human pancreatic cancer. Cancer Res. 58, 2456-2460. 

  28. Kline, C. L. and Irby, R. B. 2011. The pro-apoptotic protein Prostate Apoptosis Response Protein-4 (Par-4) can be activated in colon cancer cells by treatment with Src inhibitor and 5-FU. Apoptosis 16, 1285-1294. 

  29. Kogel, D., Plottner, O., Landsberg, G., Christian, S. and Scheidtmann, K. H. 1998. Cloning and characterization of Dlk, a novel serine/threonine kinase that is tightly associated with chromatin and phosphorylates core histones. Oncogene 17, 2645-2654. 

  30. Kogel, D., Reimertz, C., Mech, P., Poppe, M., Fruhwald, M. C., Engemann, H., Scheidtmann, K. H. and Prehn, J. H. 2001. Dlk/ZIP kinase-induced apoptosis in human medulloblastoma cells: requirement of the mitochondrial apoptosis pathway. Br. J. Cancer 85, 1801-1808. 

  31. Lee, A. S. 2009. The Par-4-GRP78 TRAIL, more twists and turns. Cancer Biol. Ther. 8, 2103-2105. 

  32. Lee, T. J., Jang, J. H., Noh, H. J., Park, E. J., Choi, K. S. and Kwon, T. K. 2010. Overexpression of Par-4 sensitizes TRAIL-induced apoptosis via inactivation of NF-kappaB and Akt signaling pathways in renal cancer cells. J. Cell. Biochem. 109, 885-895. 

  33. Lee, T. J., Lee, J. T., Kim, S. H., Choi, Y. H., Song, K. S., Park, J. W. and Kwon, T. K. 2008. Overexpression of Par-4 enhances thapsigargin-induced apoptosis via down-regulation of XIAP and inactivation of Akt in human renal cancer cells. J. Cell. Biochem. 103, 358-368. 

  34. Moreno-Bueno, G., Fernandez-Marcos, P. J., Collado, M., Tendero, M. J., Rodriguez-Pinilla, S. M., Garcia-Cao, I., Hardisson, D., Diaz-Meco, M. T., Moscat, J., Serrano, M. and Palacios, J. 2007. Inactivation of the candidate tumor suppressorpar-4 in endometrial cancer. Cancer Res. 67, 1927-1934. 

  35. Nalca, A., Qiu, S. G., El-Guendy, N., Krishnan, S. and Rangnekar, V. M. 1999. Oncogenic Ras sensitizes cells to apoptosis by Par-4. J. Biol. Chem. 274, 29976-29983. 

  36. Notaro, A., Sabella, S., Pellerito, O., Di Fiore, R., De Blasio, A., Vento, R., Calvaruso, G. and Giuliano, M. 2014. Involvement of PAR-4 in cannabinoid-dependent sensitization of osteosarcoma cells to TRAIL-induced apoptosis. Int. J. Biol. Sci. 10, 466-478. 

  37. Pereira, M. C., de Bessa-Garcia, S. A., Burikhanov, R., Pavanelli, A. C., Antunes, L., Rangnekar, V. M. and Nagai, M. A. 2013. Prostate apoptosis response-4 is involved in the apoptosis response to docetaxel in MCF-7 breast cancer cells. Int. J. Oncol. 43, 531-538. 

  38. Pruitt, K., Ulku, A. S., Frantz, K., Rojas, R. J., Muniz-Medina, V. M., Rangnekar, V. M., Der, C. J. and Shields, J. M. 2005. Ras-mediated loss of the pro-apoptotic response protein Par-4 is mediated by DNA hypermethylation through Raf-independent and Raf-dependent signaling cascades in epithelial cells. J. Biol. Chem. 280, 23363-23370. 

  39. Qiu, G., Ahmed, M., Sells, S. F., Mohiuddin, M., Weinstein, M. H. and Rangnekar, V. M. 1999. Mutually exclusive expression patterns of Bcl-2 and Par-4 in human prostate tumors consistent with down-regulation of Bcl-2 by Par-4. Oncogene 18, 623-631. 

  40. Rah, B., Amin, H., Yousuf, K., Khan, S., Jamwal, G., Mukherjee, D. and Goswami, A. 2012. A novel MMP-2 inhibitor 3-azidowithaferin A (3-azidoWA) abrogates cancer cell invasion and angiogenesis by modulating extracellular Par-4. PLoS One. 7, e44039. 

  41. Rayet, B. and Gelinas, C. 1999. Aberrant rel/nfkb genes and activity in human cancer. Oncogene 18, 6938-6947. 

  42. Schneider, B. G., Rha, S. Y., Chung, H. C., Bravo, J. C., Mera, R., Torres, J. C., Plaisance, K. T. Jr., Schlegel, R., McBride, C. M., Reveles, X. T. and Leach, R. J. 2003. Regions of allelic imbalance in the distal portion of chromosome 12q in gastric cancer. Mol. Pathol. 56, 141-149. 

  43. Schwarze, S. and Rangnekar, V. M. 2010. Targeting plasma membrane GRP78 for cancer growth inhibition. Cancer Biol. Ther. 9, 153-155. 

  44. Sells, S. F., Wood, D. P. Jr., Joshi-Barve, S. S., Muthukumar, S., Jacob, R. J., Crist, S. A., Humphreys, S. and Rangnekar, V. M. 1994. Commonality of the gene programs induced by effectors of apoptosis in androgen-dependent and -independent prostate cells. Cell Growth Differ. 5, 457-466. 

  45. Srinivasan, S., Ranga, R. S., Burikhanov, R., Han, S. S. and Chendil, D. 2007. Par-4-dependent apoptosis by the dietary compound withaferin A in prostate cancer cells. Cancer Res. 67, 246-253. 

  46. Szegezdi, E., Logue, S. E., Gorman, A. M. and Samali, A. 2006. Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep. 7, 880-885. 

  47. Thayyullathil, F., Pallichankandy, S., Rahman, A., Kizhakkayil, J., Chathoth, S., Patel, M. and Galadari, S. 2013. Caspase-3 mediated release of SAC domain containing fragment from Par-4 is necessary for the sphingosine-induced apoptosis in Jurkat cells. J. Mol. Signal. 8, 2. 

  48. Thayyullathil, F., Rahman, A., Pallichankandy, S., Patel, M. and Galadari, S. 2014. ROS-dependent prostate apoptosis response-4 (Par-4) up-regulation and ceramide generation are the prime signaling events associated with curcumin-induced autophagic cell death in human malignant glioma. FEBS Open Bio. 4, 763-776. 

  49. Zapata-Benavides, P., Mendez-Vazquez, J. L., GonzalezRocha, T. R., Zamora-Avila, D. E., Franco-Molina, M. A., Garza-Garza, R. and Rodriguez-Padilla, C. 2009. Expression of prostate apoptosis response (Par-4) is associated with progesterone receptor in breast cancer. Arch. Med. Res. 40, 595-599. 

  50. Zhao, Y., Burikhanov, R., Qiu, S., Lele, S. M., Jennings, C. D., Bondada, S., Spear, B. and Rangnekar, V. M. 2007. Cancer resistance in transgenic mice expressing the SAC module of Par-4. Cancer Res. 67, 9276-9285. 

  51. Zhao, Y. and Rangnekar, V. M. 2008. Apoptosis and tumor resistance conferred by Par-4. Cancer Biol. Ther. 7, 1867-1874. 

저자의 다른 논문 :

LOADING...

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로